313 related articles for article (PubMed ID: 17803183)
1. Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects.
Fujimura T; Shinohara Y; Tissot B; Pang PC; Kurogochi M; Saito S; Arai Y; Sadilek M; Murayama K; Dell A; Nishimura S; Hakomori SI
Int J Cancer; 2008 Jan; 122(1):39-49. PubMed ID: 17803183
[TBL] [Abstract][Full Text] [Related]
2. N-glycosylation status of beta-haptoglobin in sera of patients with prostate cancer vs. benign prostate diseases.
Yoon SJ; Park SY; Pang PC; Gallagher J; Gottesman JE; Dell A; Kim JH; Hakomori SI
Int J Oncol; 2010 Jan; 36(1):193-203. PubMed ID: 19956848
[TBL] [Abstract][Full Text] [Related]
3. N-glycosylation status of beta-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects.
Park SY; Yoon SJ; Jeong YT; Kim JM; Kim JY; Bernert B; Ullman T; Itzkowitz SH; Kim JH; Hakomori SI
Int J Cancer; 2010 Jan; 126(1):142-55. PubMed ID: 19551866
[TBL] [Abstract][Full Text] [Related]
4. Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers.
Nakano M; Nakagawa T; Ito T; Kitada T; Hijioka T; Kasahara A; Tajiri M; Wada Y; Taniguchi N; Miyoshi E
Int J Cancer; 2008 May; 122(10):2301-9. PubMed ID: 18214858
[TBL] [Abstract][Full Text] [Related]
5. Haptoglobin-beta chain defined by monoclonal antibody RM2 as a novel serum marker for prostate cancer.
Saito S; Murayama Y; Pan Y; Taima T; Fujimura T; Murayama K; Sadilek M; Egawa S; Ueno S; Ito A; Ishidoya S; Nakagawa H; Kato M; Satoh M; Endoh M; Arai Y
Int J Cancer; 2008 Aug; 123(3):633-40. PubMed ID: 18464263
[TBL] [Abstract][Full Text] [Related]
6. Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer.
Takahashi S; Sugiyama T; Shimomura M; Kamada Y; Fujita K; Nonomura N; Miyoshi E; Nakano M
Glycoconj J; 2016 Jun; 33(3):471-82. PubMed ID: 26869352
[TBL] [Abstract][Full Text] [Related]
7. Analysis of haptoglobin N-glycome alterations in inflammatory and malignant lung diseases by capillary electrophoresis.
Váradi C; Mittermayr S; Szekrényes Á; Kádas J; Takacs L; Kurucz I; Guttman A
Electrophoresis; 2013 Aug; 34(16):2287-94. PubMed ID: 23580236
[TBL] [Abstract][Full Text] [Related]
8. Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia.
Saldova R; Fan Y; Fitzpatrick JM; Watson RW; Rudd PM
Glycobiology; 2011 Feb; 21(2):195-205. PubMed ID: 20861084
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of site-specific N-glycans on sera haptoglobin β chain in liver diseases.
Zhang S; Jiang K; Sun C; Lu H; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1021-9. PubMed ID: 24103369
[TBL] [Abstract][Full Text] [Related]
10. α1-3/4 fucosylation at Asn 241 of β-haptoglobin is a novel marker for colon cancer: a combinatorial approach for development of glycan biomarkers.
Park SY; Lee SH; Kawasaki N; Itoh S; Kang K; Hee Ryu S; Hashii N; Kim JM; Kim JY; Hoe Kim J
Int J Cancer; 2012 May; 130(10):2366-76. PubMed ID: 21780104
[TBL] [Abstract][Full Text] [Related]
11. Glycosylation of site-specific glycans of alpha1-acid glycoprotein and alterations in acute and chronic inflammation.
Higai K; Aoki Y; Azuma Y; Matsumoto K
Biochim Biophys Acta; 2005 Aug; 1725(1):128-35. PubMed ID: 15863355
[TBL] [Abstract][Full Text] [Related]
12. Fucosylated haptoglobin is a novel marker for pancreatic cancer: detailed analyses of oligosaccharide structures.
Miyoshi E; Nakano M
Proteomics; 2008 Aug; 8(16):3257-62. PubMed ID: 18646007
[TBL] [Abstract][Full Text] [Related]
13. Characterization of N-glycans of recombinant human thyrotropin using mass spectrometry.
Morelle W; Donadio S; Ronin C; Michalski JC
Rapid Commun Mass Spectrom; 2006; 20(3):331-45. PubMed ID: 16372382
[TBL] [Abstract][Full Text] [Related]
14. Differences between the glycosylation patterns of haptoglobin isolated from skin scales and plasma of psoriatic patients.
Maresca B; Cigliano L; Spagnuolo MS; Dal Piaz F; Corsaro MM; Balato N; Nino M; Balato A; Ayala F; Abrescia P
PLoS One; 2012; 7(12):e52040. PubMed ID: 23272204
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer.
Lin Z; Simeone DM; Anderson MA; Brand RE; Xie X; Shedden KA; Ruffin MT; Lubman DM
J Proteome Res; 2011 May; 10(5):2602-11. PubMed ID: 21417406
[TBL] [Abstract][Full Text] [Related]
16. Glycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancer.
Tsai HY; Boonyapranai K; Sriyam S; Yu CJ; Wu SW; Khoo KH; Phutrakul S; Chen ST
Proteomics; 2011 Jun; 11(11):2162-70. PubMed ID: 21538882
[TBL] [Abstract][Full Text] [Related]
17. Disease-Specific haptoglobin N-Glycosylation in inflammatory disorders between cancers and benign diseases of 3 types of female internal genital organs.
Lai Z; Wang Z; Yuan Z; Zhang J; Zhou J; Li D; Zhang D; Li N; Peng P; Zhou J; Li Z
Clin Chim Acta; 2023 Jul; 547():117420. PubMed ID: 37285951
[TBL] [Abstract][Full Text] [Related]
18. ESI-LC-MS Method for Haptoglobin Fucosylation Analysis in Hepatocellular Carcinoma and Liver Cirrhosis.
Zhang Y; Zhu J; Yin H; Marrero J; Zhang XX; Lubman DM
J Proteome Res; 2015 Dec; 14(12):5388-95. PubMed ID: 26503433
[TBL] [Abstract][Full Text] [Related]
19.
Conroy LR; Stanback AE; Young LEA; Clarke HA; Austin GL; Liu J; Allison DB; Sun RC
Mol Cancer Res; 2021 Oct; 19(10):1727-1738. PubMed ID: 34131069
[TBL] [Abstract][Full Text] [Related]
20. N-glycans of recombinant human acid alpha-glucosidase expressed in the milk of transgenic rabbits.
Jongen SP; Gerwig GJ; Leeflang BR; Koles K; Mannesse ML; van Berkel PH; Pieper FR; Kroos MA; Reuser AJ; Zhou Q; Jin X; Zhang K; Edmunds T; Kamerling JP
Glycobiology; 2007 Jun; 17(6):600-19. PubMed ID: 17293352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
